Great West Life Assurance CO Iovance Biotherapeutics, Inc. Transaction History
Great West Life Assurance CO
- $57.4 Billion
- Q3 2024
A detailed history of Great West Life Assurance CO transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 60,749 shares of IOVA stock, worth $435,570. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,749
Previous 60,012
1.23%
Holding current value
$435,570
Previous $481,000
18.71%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding IOVA
# of Institutions
313Shares Held
237MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$196 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$191 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$172 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$152 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$94.7 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.13B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...